This is not a story about some fringe supplement claim
Translation to human outcomes is not demonstrated
Patients who should not receive BPC-157 include: those with active or recent malignancies (due to angiogenic concerns), pregnant or breastfeeding women (no reproductive toxicology data in humans), patients on anticoagulation therapy (theoretical bleeding risk from angiogenesis at ulcer sites), and minors (no pediatric data of any kind)
Sin embargo, este estudio tena limitaciones significativas, como la falta de un grupo de control y el pequeo tamao de la muestra
Memory retention Focus and clarity Cognitive performance Brain repair and neural connectivity Can Dihexa be used for brain injury or Alzheimers
In assays measuring neurotrophic activity, Dihexa demonstrated potency seven orders of magnitude greater than BDNF, one of the brains primary growth factors